Metabolic Disorders
GlobalData’s reports offer expert analysis, insights and opinions to companies in the world’s largest industries. Explore unique market-leading data today and benefit from access to actionable insight within the Metabolic Disorders market. Reports cover market growth forecasts, trends and research, and more.
Browse our full list of Metabolic Disorders market reports here.
- Currency Conversion is for Indicative purpose only. All orders are processed in US Dollars only.
- USD - US Dollar
- AUD — Australian Dollar
- BRL — Brazilian Real
- CNY — Yuan Renminbi
- EUR — Euro
- GBP — Pound Sterling
- INR — Indian Rupee
- JPY — Japanese Yen
- ZAR — South African Rand
- The Price Conversion is only for the Indicative purpose.
- USD — US Dollar
- AUD — Australian Dollar
- BRL — Brazilian Real
- CNY — Yuan Renminbi
- EUR — Euro
- GBP — Pound Sterling
- INR — Indian Rupee
- JPY — Japanese Yen
- ZAR — South African Rand
-
Product Insights
Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H2, 2017 Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H2, 2017
$2,500 | August 2017 GlobalData's clinical trial report, “Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H2, 2017" provides an overview of Pre-Diabetes/Impaired Glucose Tolerance clinical trials scenario. This report provides top line data relating to the clinical trials on Pre-Diabetes/Impaired Glucose Tolerance. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Gestational Diabetes Global Clinical Trials Review, H2, 2017 Gestational Diabetes Global Clinical Trials Review, H2, 2017
$2,500 | August 2017 GlobalData's clinical trial report, “Gestational Diabetes Global Clinical Trials Review, H2, 2017" provides an overview of Gestational Diabetes clinical trials scenario. This report provides top line data relating to the clinical trials on Gestational Diabetes. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Glucocorticoid-Induced Osteoporosis Global Clinical Trials Review, H2, 2017 Glucocorticoid-Induced Osteoporosis Global Clinical Trials Review, H2, 2017
$2,500 | August 2017 GlobalData's clinical trial report, “Glucocorticoid-Induced Osteoporosis Global Clinical Trials Review, H2, 2017" provides an overview of Glucocorticoid-Induced Osteoporosis clinical trials scenario. This report provides top line data relating to the clinical trials on Glucocorticoid-Induced Osteoporosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Glucose Intolerance Global Clinical Trials Review, H2, 2017 Glucose Intolerance Global Clinical Trials Review, H2, 2017
$2,500 | August 2017 GlobalData's clinical trial report, “Glucose Intolerance Global Clinical Trials Review, H2, 2017" provides an overview of Glucose Intolerance clinical trials scenario. This report provides top line data relating to the clinical trials on Glucose Intolerance. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Diabetes Insipidus Disease - Global Clinical Trials Review, H1 2019 Diabetes Insipidus Disease - Global Clinical Trials Review, H1 2019
$2,500 | May 2019 GlobalData's clinical trial report, “Diabetes Insipidus Global Clinical Trials Review, H1, 2019" provides an overview of Diabetes Insipidus clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetes Insipidus. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Diabetic Complications Disease - Global Clinical Trials Review, H1 2019 Diabetic Complications Disease - Global Clinical Trials Review, H1 2019
$2,500 | May 2019 GlobalData's clinical trial report, “Diabetic Complications Global Clinical Trials Review, H1, 2019" provides an overview of Diabetic Complications clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Complications. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Diabetic Foot Infection (DFI) Disease - Global Clinical Trials Review, H1 2019 Diabetic Foot Infection (DFI) Disease - Global Clinical Trials Review, H1 2019
$2,500 | May 2019 GlobalData's clinical trial report, “Diabetic Foot Infection (DFI) Global Clinical Trials Review, H1, 2019" provides an overview of Diabetic Foot Infection (DFI) clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Foot Infection (DFI). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Diabetic Ketoacidosis Disease - Global Clinical Trials Review, H1 2019 Diabetic Ketoacidosis Disease - Global Clinical Trials Review, H1 2019
$2,500 | May 2019 GlobalData's clinical trial report, “Diabetic Ketoacidosis Global Clinical Trials Review, H1, 2019" provides an overview of Diabetic Ketoacidosis clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Ketoacidosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Diabetic Nephropathy Disease - Global Clinical Trials Review, H1 2019 Diabetic Nephropathy Disease - Global Clinical Trials Review, H1 2019
$2,500 | May 2019 GlobalData's clinical trial report, “Diabetic Nephropathy Global Clinical Trials Review, H1, 2019" provides an overview of Diabetic Nephropathy clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Nephropathy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Diabetic Neuropathic Foot Ulcers Disease - Global Clinical Trials Review, H1 2019 Diabetic Neuropathic Foot Ulcers Disease - Global Clinical Trials Review, H1 2019
$2,500 | May 2019 GlobalData's clinical trial report, “Diabetic Neuropathic Foot Ulcers Global Clinical Trials Review, H1, 2019" provides an overview of Diabetic Neuropathic Foot Ulcers clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Neuropathic Foot Ulcers. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.